<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04622852</url>
  </required_header>
  <id_info>
    <org_study_id>2017/681</org_study_id>
    <nct_id>NCT04622852</nct_id>
  </id_info>
  <brief_title>Pegs for Osteofixation of Proximal Humeral Fractures</brief_title>
  <official_title>Are Pegs Better Than Screw for Osteofixation of Proximal Humeral Fractures?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients treated operative for Proximal humeral fractures with angular stable device (Philos&#xD;
      plate or ALPS-PHP)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      From a cohort of patients treated for displaced Proximal humeral fractures (PHF) in the&#xD;
      period July 2017 - August 2019 patients with the 11-B2 and 11-C2 PHF according to AO/OTA 2007&#xD;
      fracture classification were selected according to age and gender to be compared with&#xD;
      patients operated with a Philos plate within the same fracture group, age and gender to be&#xD;
      matched for adverse events:&#xD;
&#xD;
        1. Radiographic evidence of penetration of pegs (ALPS-PHP) or screws (Philos) into the&#xD;
           glenohumeral joint (primary outcome) and&#xD;
&#xD;
        2. Avascular head necrosis / sinking / need of re-surgery&#xD;
&#xD;
        3. Clinical PROMS&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Actual">August 1, 2021</completion_date>
  <primary_completion_date type="Actual">September 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Peg penetration into glenohumeral joint</measure>
    <time_frame>12 months</time_frame>
    <description>Radiographic or CT verified peg penetration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Screw penetration into glenohumeral joint</measure>
    <time_frame>12 months</time_frame>
    <description>Radiographic or CT verified screw penetration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Humeral head deformation</measure>
    <time_frame>12 months</time_frame>
    <description>Avascular head necrosis or Sinking</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shoulder function</measure>
    <time_frame>12 months</time_frame>
    <description>Constant-Murley score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self reported shoulder function</measure>
    <time_frame>12 months</time_frame>
    <description>Oxford scoulder score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 months</time_frame>
    <description>Generic 15D score</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">38</enrollment>
  <condition>Implant Complication</condition>
  <condition>Proximal Humeral Fracture</condition>
  <condition>Avascular Necrosis of Humerus</condition>
  <arm_group>
    <arm_group_label>Group A: ALPS-PHP device</arm_group_label>
    <description>Patients operated with angular stable plate for displaced PHF with an ALPS plate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B: Philos device</arm_group_label>
    <description>Patients operated with angular stable plate for displaced PHF with a Philos plate</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Open reduction internal fixation (ORIF) with an angular stable plate</intervention_name>
    <description>Operative treatment of proximal humeral fracture</description>
    <arm_group_label>Group A: ALPS-PHP device</arm_group_label>
    <arm_group_label>Group B: Philos device</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to hospital with an acute PHF for surgical treatment&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criterion:&#xD;
&#xD;
          -  Acute proximal humeral fracture&#xD;
&#xD;
          -  AO/OTA type 11-B2 or 11C2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not eligible to surgical treatment&#xD;
&#xD;
          -  Non-compliant&#xD;
&#xD;
          -  Former shoulder fracture or symptomatic shoulder illness&#xD;
&#xD;
          -  Drug abuser&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tore Fjalestad, MD, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital, Ortophaedic Dept.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>November 3, 2020</study_first_submitted>
  <study_first_submitted_qc>November 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2020</study_first_posted>
  <last_update_submitted>September 12, 2021</last_update_submitted>
  <last_update_submitted_qc>September 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Tore Fjalestad</investigator_full_name>
    <investigator_title>MD. PhD. Senior Consultant Ortophaedic Surgeon</investigator_title>
  </responsible_party>
  <keyword>Humeral head</keyword>
  <keyword>Screw penetration</keyword>
  <keyword>Peg penetration</keyword>
  <keyword>Avascular necrosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Humeral Fractures</mesh_term>
    <mesh_term>Shoulder Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>No plan has been decided</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

